Home
Arch Venture Fund X Overage, 10% Owner: Neumora Therapeutics NMRA Buy · Filed 25/10/29
Trade details
- Type
- Insider buy
- Amount
- $4,999,977
- Shares · price
- 1,915,700 sh · $2.61 a share
- Held after
- 6,046,907 sh
- Trade date
- 25/10/27
- Filed
- 25/10/29
- Days to filing
- 2 days
First buy in 2 years
- Since the last buy
- 2.1 years
- Last buy
- 23/09/19
- Insiders buying this week
- 18 insiders
- Holding change
- +46.4%
Neumora Therapeutics trades, last 26 weeks
What else happened in Neumora Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/27~25/11/26Arch Venture Fund X Overage's recent trades
- Arch Venture Fund X Overage
BuyPrime Medicine
BuyPrime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
- Arch Venture Fund X Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$2.1M
133,333 sh
$2.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund X Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$1.1M
66,667 sh
$1.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund X Overage
BuyPrime Medicine
BuyPrime Medicine
PRME
$20M
3,200,000 sh
$20M
Filed 24/02/20
Traded 24/02/15
- Arch Venture Fund X Overage
BuySana Biotechnology
BuySana Biotechnology
SANA
$4M
727,272 sh
$4M
Filed 24/02/12
Traded 24/02/08
